The importance of developing new mannan tests in the diagnosis of invasive candidiasis in oncology patients

The regimens of anticancer therapy have been intensified and methods of high-dose chemotherapy (HDCT) have been introduced for recent years which made it possible to achieve significant progress in the results of tumor treatments. Intensification of chemotherapy regimens in cancer patients leads to...

Full description

Saved in:
Bibliographic Details
Main Authors: O. Yu. Kutsevalova, Yu. Yu. Kozel, N. E. Nifantiev, A. V. Antonets, V. B. Krylov
Format: Article
Language:Russian
Published: ANO "Perspective of oncology" 2021-09-01
Series:Южно-Российский онкологический журнал
Subjects:
Online Access:https://www.cancersp.com/jour/article/view/121
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849389007589343232
author O. Yu. Kutsevalova
Yu. Yu. Kozel
N. E. Nifantiev
A. V. Antonets
V. B. Krylov
author_facet O. Yu. Kutsevalova
Yu. Yu. Kozel
N. E. Nifantiev
A. V. Antonets
V. B. Krylov
author_sort O. Yu. Kutsevalova
collection DOAJ
description The regimens of anticancer therapy have been intensified and methods of high-dose chemotherapy (HDCT) have been introduced for recent years which made it possible to achieve significant progress in the results of tumor treatments. Intensification of chemotherapy regimens in cancer patients leads to the emergence of risk factors of invasive candidiasis (IC) development: agranulocytosis, disruption of the integrity of the mucous membranes, prolonged use of CVC, repeated antibiotic therapy, long-term parenteral nutrition. Thus, intensification of anticancer therapy may be accompanied by an increase in infection-mediated mortality.IC is the most common invasive mycosis in Russia. More than 11 thousand cases of IC occur in our country every year. The frequency IC in Russia is 8.29 per 100 thousand of the population, which corresponds to the results of the LIFE study in European countries where this indicator varies from 2.2 to 11 per 100 thousand of the population. There are no clinical signs or symptoms specific for IC. It develops in patients with concomitant diseases, which significantly complicates the diagnosis. In this regard, an urgent issue is to improve the diagnosis of candidal infectious complications in cancer patients in order to optimize treatment by studying serological markers that have the greatest value in the diagnosis of infectious complications in cancer patients.
format Article
id doaj-art-68f3828bf5e642eea864a3d7f7a9ea06
institution Kabale University
issn 2686-9039
language Russian
publishDate 2021-09-01
publisher ANO "Perspective of oncology"
record_format Article
series Южно-Российский онкологический журнал
spelling doaj-art-68f3828bf5e642eea864a3d7f7a9ea062025-08-20T03:42:06ZrusANO "Perspective of oncology"Южно-Российский онкологический журнал2686-90392021-09-0123424710.37748/2686-9039-2021-2-3-580The importance of developing new mannan tests in the diagnosis of invasive candidiasis in oncology patientsO. Yu. Kutsevalova0Yu. Yu. Kozel1N. E. Nifantiev2A. V. Antonets3V. B. Krylov4National Medical Research Centre for Oncology of the Ministry of Health of RussiaNational Medical Research Centre for Oncology of the Ministry of Health of RussiaN.D.Zelinsky Institute of Organic Chemistry of the Russian Academy of SciencesN.D.Zelinsky Institute of Organic Chemistry of the Russian Academy of Sciences; Rostov State Medical UniversityN.D.Zelinsky Institute of Organic Chemistry of the Russian Academy of SciencesThe regimens of anticancer therapy have been intensified and methods of high-dose chemotherapy (HDCT) have been introduced for recent years which made it possible to achieve significant progress in the results of tumor treatments. Intensification of chemotherapy regimens in cancer patients leads to the emergence of risk factors of invasive candidiasis (IC) development: agranulocytosis, disruption of the integrity of the mucous membranes, prolonged use of CVC, repeated antibiotic therapy, long-term parenteral nutrition. Thus, intensification of anticancer therapy may be accompanied by an increase in infection-mediated mortality.IC is the most common invasive mycosis in Russia. More than 11 thousand cases of IC occur in our country every year. The frequency IC in Russia is 8.29 per 100 thousand of the population, which corresponds to the results of the LIFE study in European countries where this indicator varies from 2.2 to 11 per 100 thousand of the population. There are no clinical signs or symptoms specific for IC. It develops in patients with concomitant diseases, which significantly complicates the diagnosis. In this regard, an urgent issue is to improve the diagnosis of candidal infectious complications in cancer patients in order to optimize treatment by studying serological markers that have the greatest value in the diagnosis of infectious complications in cancer patients.https://www.cancersp.com/jour/article/view/121invasivecandidiasiscandidemiaoncologycandida sppmannan
spellingShingle O. Yu. Kutsevalova
Yu. Yu. Kozel
N. E. Nifantiev
A. V. Antonets
V. B. Krylov
The importance of developing new mannan tests in the diagnosis of invasive candidiasis in oncology patients
Южно-Российский онкологический журнал
invasive
candidiasis
candidemia
oncology
candida spp
mannan
title The importance of developing new mannan tests in the diagnosis of invasive candidiasis in oncology patients
title_full The importance of developing new mannan tests in the diagnosis of invasive candidiasis in oncology patients
title_fullStr The importance of developing new mannan tests in the diagnosis of invasive candidiasis in oncology patients
title_full_unstemmed The importance of developing new mannan tests in the diagnosis of invasive candidiasis in oncology patients
title_short The importance of developing new mannan tests in the diagnosis of invasive candidiasis in oncology patients
title_sort importance of developing new mannan tests in the diagnosis of invasive candidiasis in oncology patients
topic invasive
candidiasis
candidemia
oncology
candida spp
mannan
url https://www.cancersp.com/jour/article/view/121
work_keys_str_mv AT oyukutsevalova theimportanceofdevelopingnewmannantestsinthediagnosisofinvasivecandidiasisinoncologypatients
AT yuyukozel theimportanceofdevelopingnewmannantestsinthediagnosisofinvasivecandidiasisinoncologypatients
AT nenifantiev theimportanceofdevelopingnewmannantestsinthediagnosisofinvasivecandidiasisinoncologypatients
AT avantonets theimportanceofdevelopingnewmannantestsinthediagnosisofinvasivecandidiasisinoncologypatients
AT vbkrylov theimportanceofdevelopingnewmannantestsinthediagnosisofinvasivecandidiasisinoncologypatients
AT oyukutsevalova importanceofdevelopingnewmannantestsinthediagnosisofinvasivecandidiasisinoncologypatients
AT yuyukozel importanceofdevelopingnewmannantestsinthediagnosisofinvasivecandidiasisinoncologypatients
AT nenifantiev importanceofdevelopingnewmannantestsinthediagnosisofinvasivecandidiasisinoncologypatients
AT avantonets importanceofdevelopingnewmannantestsinthediagnosisofinvasivecandidiasisinoncologypatients
AT vbkrylov importanceofdevelopingnewmannantestsinthediagnosisofinvasivecandidiasisinoncologypatients